Among the clinical antidiabetic drugs, thiazolidinediones (TZDs) do not cause hypoglycemia like insulin or insulin secretagogues (i.e., sulfonylureas) and can be used in combination with other antidiabetic drugs to significantly ameliorate insulin sensitivity and provide long-lasting glycemic control [11]. This evidence concerns the gene INS and Hypoglycemia.